期刊文献+

RNA干涉宫颈癌细胞抑制HPV16 E6基因表达对FHIT基因表达的影响 被引量:2

Effect of inhibited HPV16 E6 expression by RNA interference on FHIT gene expression in cervical cancer cells
下载PDF
导出
摘要 目的:研究HPV16 E6基因被RNA干涉抑制后FHIT基因表达的变化,探讨两者在宫颈癌组织中的相关性。方法:合成针对HPV16 E6基因的特异性si RNA,脂质体介导转染宫颈癌CaSki细胞,RT-PCR测定转染前后HPV16E6、FHIT基因mRNA表达;Western blot和流式细胞仪检测转染前后HPV16E6、FHIT蛋白表达情况。结果:将HPV16 E6 si RNA转染CaSki细胞后48h,HPV16E6mRNA表达水平较转染前降低了80.3%,P<0.01;FHIT mRNA的表达水平较转染前升高了41.7%,P<0.01。转染前后HPV16E6蛋白表达水平分别为26.7±3.3和8.2±1.1,t=14.224,P=0.005;FHIT蛋白表达水平分别为73.5±5.6和109.9±5.1,t=22.018,P=0.002。结论:抑制HPV16 E6基因的表达可使宫颈癌组织中FHIT基因的表达增加。 OBJECTIVE:To detect the changes of FHIT gene expression after the HPV16 E6 gene expression was inhibited by RNA interference, and explore the relationship between HPV16 E6 and FHIT gene in cervical neoplasms. METHODS:The specific small interfering RNA (siRNA) of HPV16 E6 gene was synthesized and transfected into cervical cancer cell line CaSki. The mRNA levels of HPV16 E6 and FHIT before and after transfection were measured by RT PCR, and the protein levels of HPV16 E6 and FHIT were measured by Western blot and flow cytometry. RESULTS: The mRNA level of HPV16 E6 reduced by 80.3% at 48 hours after transfection (P〈0.01), but the mRNA level of FHIT was 41.7 % higher than before at 48 hours after transfection (P〈0.01). The protein levels of HPV16 E6 before and after transfection were (26.7±3.3) and (8.2± 1.1), respectively,t 14.224,P=0.005; The protein levels of FHIT before and after transfection were (73.5±5.6) and (109.9±5.1),respectively,t= 22. 018,P=0. 002. CONCLUSION: FHIT gene expression can be up regulated by inhibition of the expression of HPV16 E6 gene in cervical neoplasms.
出处 《中华肿瘤防治杂志》 CAS 2007年第21期1605-1608,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30371483)
关键词 宫颈肿瘤/病理学 RNA干扰 基因表达 乳头状瘤病毒 流式细胞术 cervix neoplasms/pathology RNA interference gene expression papillomavirus, human flow cytometry
  • 相关文献

参考文献16

  • 1Lowy D R, Kirnbaner R, Schiller J T, et al. Genital human papillomavirus infection[J]. Proc Natl Acad Sci USA, 1994, 91(7) : 2436--2440.
  • 2Seedorf K, Kraemmer C, Duerst M, et al. Human papillomavirus type 16 DNA sequence[J]. Virology, 1985, 145(1): 181-185.
  • 3Ohta M, Inoue H, Cottieelli M G, et al. The FHIT gene,spanning the chromosome 3p14.2 frigile site and renal carcinoma-associated t(3-8)breakpoint, is abnormal in digestive tract cancers [J]. Cell, 1996,84(4):587--597.
  • 4Shridhar R, Shridhar V, Wang X, et al. Frequent breackpoints in the 3p14. 2 fragile site, FRA3B, in pancreatic tumors[J]. Cancer Res, 1996, 56(19):4347--4350.
  • 5Sozzi G, Veronese M L, Negrini M, et al. The FHIT gene 3p14.2 is abnormal In lung cancer[J]. Cell,1996, 85(1): 17-26.
  • 6Larson A A, Kern S, Curitiss S, et al. High resolution analysis of chromosome 3p alterations in cervical carcinoma[J]. Cancer Res, 1997, 57(18):4082--4090.
  • 7Kalantari M, Blennow E, Hagmar B, et al. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas[J]. Diagn Mol Pathol, 2001,10(1) : 46--54.
  • 8牛晓宇,彭芝兰,王和.RNA干涉抑制宫颈癌CaSki细胞株HPV16 E6基因的研究[J].癌症,2004,23(11):1257-1262. 被引量:27
  • 9Kunke D, Grimm D, Denger S, et al. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors[J]. Cancer Gene Ther, 2000, 7(5):766--777.
  • 10Wake N. Application of antisense oligonucleotides into treatment of human cervical carcinoma[J]. Nippon Sanka Fujink Zasshi, 1994, 46(8): 742-748.

二级参考文献22

  • 1Ausubel FM等 颜子颖 等.精编分子生物学实验指南[M].北京:科学出版社,1998.120-45.
  • 2Lee CJ,Suh EJ,Kang HT,et al.Induction of senescence like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV 16 DNA [J].Exp Cell Res,2002,277(2):173-182.
  • 3Tan TM,Ting RC.In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes [J].Cancer Res,1995,55(20):4599-4605.
  • 4Choo CK,Ling MT,Suen CK,et al.Retrovirus mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of Caski cells [J].Gynecol Oncol,2000,78(3 pt 1):293-301.
  • 5Storey A,Oates D,Banks L,et al.Anti sense phosphorothioate oligonucleotides have both specific and non specific effects on cells containing human papillomavirus type 16 [J].Nucleic Acids Res,1999,19(15):4109-4114.
  • 6Waterhouse PM,Wang MB,Lough T.Gene silencing as an adaptive defense against viruses [J].Nature,2001,411(14):834-842.
  • 7Paul CP,Good PD,Winer I,et al.Effective expression of small interfering RNA in human cells [J].Nat Biotechnol,2002,20(5):505-508.
  • 8Smalheiser NR,Manev H,Costa E.RNAi and brain function: was McConnell on the right track? [J].Trends Neurosci,2001,24(4):216-218.
  • 9Sui G,Soohoo C,Affar el B,et al.A DNA vector based RNAi technology to suppress gene expression in mammalian cells [J].Proc Natl Acad Sci USA,2002,99(8):5515-5520.
  • 10Elbashir SM,Harborth J,Weber K,et al.Analysis of gene function in somatic mammalian cells using small interfering RNAs [J].Methods,2002,26(2):199-213.

共引文献29

同被引文献19

  • 1赵立民,罗红敏,王春英,李翎.rBCG-HPV16 E6-E7疫苗的构建和免疫原性研究[J].中华肿瘤防治杂志,2006,13(8):600-603. 被引量:4
  • 2Zur Hausen H. Papillomaviruses in human cancer[J]. Cancer, 1987,69(10) : 1692-1696.
  • 3Werness B A, Levine A J, Howley P M. Association of human papillomavirus types 16 and 18 E6 proteins with p53[J]. Science,1990,248(4951) :76-79.
  • 4Sherman L, Schlegel R. Serum and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16[J]. J Virol, 1996,70 (5) : 3269- 3279.
  • 5Liang X H, Volkmann M, Klein R, et al. Co-localization of the tumor suppressor protein p53 and human papillomavirus. E6 protein in human cervical carcinoma cell lines[J]. Oncogene, 1993,8(10) :2645-2652.
  • 6Tao M, Kruhlak M, Zheng Z M, et al. Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells[J]. J Virol,2003,77(24):13232-13247.
  • 7Schoppmeier J, Mages W, Leehtreek K F. GFP as a tool for the analysis of proteins in the flagellar basal apparatus of chlamydomonas[J]. Cell Motil Cytoskeleton, 2005,61(4) : 189-200.
  • 8Zheng Y, Zhang J, Rao Z. Ribozyme targeting HPV16 E6E7 transcripts in cervical cancer cells suppresses cell growth and sensitizes cells to chemotherapy and radiotherapy[J]. Cancer Biol Ther,2004,3(11):1129-1134.
  • 9Massimi P, Gammoh N, Thomas M,et al. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradaion[J]. Oncogene, 2004,23(29) :8033-8039.
  • 10Levine A J. p53, the cellular gatekeeper for growth and division [J]. Cell,1997,88(3):323-331.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部